PC
PointState Capital Portfolio holdings
AUM
$4.67B
This Quarter Return
+2.76%
1 Year Return
+24.63%
3 Year Return
+80.28%
5 Year Return
+158.5%
10 Year Return
+665.76%
AUM
$8.71B
AUM Growth
+$8.71B
(-8%)
Cap. Flow
-$802M
Cap. Flow
% of AUM
-9.21%
Top 10 Holdings %
Top 10 Hldgs %
36.68%
Holding
196
New
59
Increased
31
Reduced
34
Closed
50
Top Buys
| 1 |
Lam Research
LRCX
|
$378M |
| 2 |
Microsoft
MSFT
|
$320M |
| 3 |
Adobe
ADBE
|
$227M |
| 4 |
Alibaba
BABA
|
$173M |
| 5 |
Lowe's Companies
LOW
|
$167M |
Top Sells
| 1 |
Wells Fargo
WFC
|
$459M |
| 2 |
Amazon
AMZN
|
$372M |
| 3 |
Nektar Therapeutics
NKTR
|
$351M |
| 4 |
Devon Energy
DVN
|
$293M |
| 5 |
Comcast
CMCSA
|
$221M |
Sector Composition
| 1 | Technology | 22.29% |
| 2 | Financials | 14.21% |
| 3 | Healthcare | 13.08% |
| 4 | Energy | 13.02% |
| 5 | Materials | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDCO
26
DELISTED
Medicines Co
MDCO
| $122M | 1.33% |
3,706,147
+1,663,694
| +81% | +$54.8M |
|
27
Regions Financial
RF
$23.9B
| $121M | 1.31% |
6,489,300
+6,283,500
| +3,053% | +$117M |
|
28
Stellantis
STLA
$26.3B
| $115M | 1.26% |
+5,620,666
| New | +$115M |
|
29
Viatris
VTRS
$12.3B
| $113M | 1.23% |
2,754,090
+83,175
| +3% | +$3.42M |
|
|
LLL
30
DELISTED
L3 Technologies, Inc.
LLL
| $112M | 1.22% |
538,612
+526,012
| +4,175% | +$109M |
|
31
Goldman Sachs
GS
$220B
| $109M | 1.19% |
+433,509
| New | +$109M |
|
|
TWX
32
DELISTED
Time Warner Inc
TWX
| $103M | 1.12% |
1,088,777
+811,238
| +292% | +$76.7M |
|
33
Northrop Grumman
NOC
$82.9B
| $100M | 1.09% |
+286,399
| New | +$100M |
|
34
Gilead Sciences
GILD
$140B
| $86.6M | 0.94% |
+1,148,301
| New | +$86.6M |
|
35
Transportadora de Gas del Sur
TGS
$3.84B
| $77.2M | 0.84% |
3,795,065
| – | – |
|
36
Cigna
CI
$80.1B
| $76.3M | 0.83% |
+454,705
| New | +$76.3M |
|
37
CME Group
CME
$96.6B
| $75.6M | 0.82% |
+467,500
| New | +$75.6M |
|
38
Plains GP Holdings
PAGP
$3.7B
| $75M | 0.82% |
3,449,543
+1,013,543
| +42% | +$22M |
|
|
AVXS
39
DELISTED
AveXis, Inc. Common Stock
AVXS
| $72.5M | 0.79% |
586,347
+372,780
| +175% | +$46.1M |
|
|
40
Nektar Therapeutics
NKTR
$540M
| $66.2M | 0.72% |
623,316
-3,302,354
| -84% | -$351M |
|
41
Pacira BioSciences
PCRX
$1.22B
| $63.5M | 0.69% |
2,038,153
+847,146
| +71% | +$26.4M |
|
|
X
42
DELISTED
US Steel
X
| $60.1M | 0.65% |
+1,707,200
| New | +$60.1M |
|
43
JD.com
JD
$44.1B
| $57.1M | 0.62% |
+1,410,305
| New | +$57.1M |
|
44
Zimmer Biomet
ZBH
$20.7B
| $56M | 0.61% |
+513,497
| New | +$56M |
|
45
AB InBev
BUD
$116B
| $54.3M | 0.59% |
+494,100
| New | +$54.3M |
|
|
SUPV
46
Grupo Supervielle
SUPV
$650M
| $53.9M | 0.59% |
1,775,362
-334,500
| -16% | -$10.1M |
|
47
Union Pacific
UNP
$131B
| $51.9M | 0.56% |
385,931
-177,769
| -32% | -$23.9M |
|
48
Merck
MRK
$211B
| $50.3M | 0.55% |
+923,600
| New | +$50.3M |
|
49
Vertex Pharmaceuticals
VRTX
$101B
| $48.7M | 0.53% |
298,677
-275,613
| -48% | -$44.9M |
|
|
ALXN
50
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $48.2M | 0.52% |
+432,400
| New | +$48.2M |
|